Literature DB >> 16404630

[Escalating management of progressive neuropathic cancer pain].

D Heinrichs1, T Fritz, H Otto, K Diehlmann, R Matejec, G Hempelmann.   

Abstract

The management of tumor-related pain, particularly that which is neuropathic in origin, is both difficult and challenging. According to WHO guidelines, opioids are the first-line analgesics in case of severe tumor-related pain syndromes. Some patients receiving continuous opioid therapy rapidly require increase of the opioid dose. In this case it can be necessary to extend the analgesic regime and to either apply interventional procedures or change the opioid or the route of administration. The case presented is remarkable regarding the severity and persistent nature of the patient's pain despite a variety of commonly employed treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404630     DOI: 10.1007/s00482-005-0461-4

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  19 in total

Review 1.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

Review 2.  Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

Authors:  Jianren Mao; Donald D Price; David J Mayer
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

3.  Spinal epidural metastasis: implications for spinal analgesia to treat "refractory" cancer pain.

Authors:  L Appelgren; C Nordborg; M Sjöberg; P A Karlsson; P Nitescu; I Curelaru
Journal:  J Pain Symptom Manage       Date:  1997-01       Impact factor: 3.612

4.  Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain.

Authors:  P Nitescu; L Appelgren; L E Linder; M Sjöberg; E Hultman; I Curelaru
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612

5.  Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section.

Authors: 
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

6.  Age-dependent opioid escalation in chronic pain patients.

Authors:  Chante Buntin-Mushock; Lisa Phillip; Kumi Moriyama; Pamela Pierce Palmer
Journal:  Anesth Analg       Date:  2005-06       Impact factor: 5.108

7.  NCCN Practice Guidelines for Cancer Pain.

Authors:  C Benedetti; C Brock; C Cleeland; N Coyle; J E Dubé; B Ferrell; S Hassenbusch; N A Janjan; M J Lema; M H Levy; M J Loscalzo; M Lynch; C Muir; L Oakes; A O'Neill; R Payne; K L Syrjala; S Urba; S M Weinstein
Journal:  Oncology (Williston Park)       Date:  2000-11       Impact factor: 2.990

8.  Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology.

Authors:  T Meuser; C Pietruck; L Radbruch; P Stute; K A Lehmann; S Grond
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

9.  Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients.

Authors:  R T van Dongen; B J Crul; J van Egmond
Journal:  Clin J Pain       Date:  1999-09       Impact factor: 3.442

10.  Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism.

Authors:  Jianren Mao; Backil Sung; Ru-Rong Ji; Grewo Lim
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.